Integra LifeSciences (Integra) was founded in 1989 based on a vision to expand access to promising technology that enables the body to regenerate damaged or diseased tissue. Grounded on this vision, the company revolutionized the field of regenerative medicine and has since grown to be a leading global medical technology company innovating new treatment pathways in surgical, neurologic and regenerative care to advance patient outcomes and set new standards of care. Integra now has a broad portfolio of innovative products and solutions used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus, hemorrhagic stroke, and other neurological and ear, nose and throat conditions. Our regenerative tissue technologies include products that address soft tissue, peripheral nerve and tendon repairs and are used for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery.